BERLIN, Germany and ATLANTA, Georgia, September 26, 2023 / B3C newswire / ProBioGen and GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, announce the signing of a landmark commercial license agreement for ProBioG.